LEAK-OUT AND SUPPORT AGREEMENTLeak-Out and Support Agreement • August 10th, 2020 • Akers Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
THIS LEAK-OUT AND SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of August 3, 2020, by and among Akers Biosciences, Inc. (the “Company”) and ChubeWorkx Guernsey Limited (the “Stockholder”).
SETTLEMENT AGREEMENT AND GENERAL RELEASESettlement Agreement and General Release • August 10th, 2020 • Akers Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
This Settlement Agreement and General Release (this “Agreement”), is made as of August 3, 2020 (the “Effective Date”), by and between (i) ChubeWorkx Guernsey Limited, a company registered in Guernsey as company number 55801 and has its registered office at 18-20 Le Pollet, St Peter Port, Guernsey, GY1 1WH (“ChubeWorkx”) and (ii) Akers BioSciences, Inc., a New Jersey corporation and having its principal place of business at 201 Grove Road, Thorofare, New Jersey, 08086, United States of America (“Akers”). ChubeWorkx and Akers are herein sometimes jointly referred to as the “Parties” and each individually as a “Party.”
